Katsuaki Inagaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Katsuaki Inagaki has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Hidenori Tanaka
Department of Gastroenterology Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
3 shared publications Yuki Okamoto
Department of Gastroenterology Hiroshima University Hospital Hiroshima Japan
3 shared publicationsHirosato Tamari
Department of Gastroenterology Hiroshima University Hospital Hiroshima Japan
2 shared publications- Kazuaki Chayama
Collaborative Research Laboratory of Medical Innovation, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
2 shared publications - Ken Yamashita
Department of Plastic and Reconstructive Surgery, Sapporo Medical University school of Medicine, Sapporo, Hokkaido, Japan
2 shared publications Kenta Matsumoto
2 shared publications
Latest Publications
- Open Access
Clinical outcomes of endoscopic submucosal dissection for large pedunculated colorectal carcinoma: A retrospective multicenter study
Objectives: Complete en‐bloc resection of pedunculated colorectal carcinoma is necessary for a proper pathological diagnosis. However, due to poor visibility, large pedunculated colorectal carcinomas are difficult to snare and resect en‐bloc using endoscopic resection or polypectomy. Additionally, the bleeding risk of large pedunculated colorectal carcinomas is relatively high. We aimed to assess the feasibility and safety of endoscopic submucosal dissection for large pedunculated colorectal carcinomas.Methods: We conducted a retrospective multicenter cohort study to assess 36 consecutive patients with 36 large pedunculated colorectal carcinomas who underwent endoscopic submucosal dissection and evaluated the outcomes of endoscopic submucosal dissection. Furthermore, patients were divided into two groups according to the procedure time, and the factors related to the procedure time were assessed.Results: The mean tumor size was 34.1 ± 9.9 mm. The en‐bloc, complete en‐bloc, and curative resection rates were 97% (35/36), 97% (35/36), and 81% (29/36), respectively. The rate of severe bleeding during the procedure was 11% (4/36); however, it could be controlled endoscopically in all patients. The rate of intraoperative perforation and delayed bleeding was 0% (0/36). Delayed perforations occurred in one patient that required surgery. A long procedure time was correlated with the location of the flexure and poor endoscope operability. No recurrence was observed in any patient. None of the patients died of colorectal carcinoma.Conclusions: Our results showed the feasibility and safety of endoscopic submucosal dissection for large pedunculated colorectal carcinomas.
Open AccessClinical outcomes of endoscopic submucosal dissection for large pedunculated colorectal carcinoma: A retrospective multicenter study
Objectives: Complete en‐bloc resection of pedunculated colorectal carcinoma is necessary for a proper pathological diagnosis. However, due to poor visibility, large pedunculated colorectal carcinomas are difficult to snare and resect en‐bloc using endoscopic resection or polypectomy. Additionally, the bleeding risk of large pedunculated colorectal carcinomas is relatively high. We aimed to assess the feasibility and safety of endoscopic submucosal dissection for large pedunculated colorectal carcinomas.Methods: We conducted a retrospective multicenter cohort study to assess 36 consecutive patients with 36 large pedunculated colorectal carcinomas who underwent endoscopic submucosal dissection and evaluated the outcomes of endoscopic submucosal dissection. Furthermore, patients were divided into two groups according to the procedure time, and the factors related to the procedure time were assessed.Results: The mean tumor size was 34.1 ± 9.9 mm. The en‐bloc, complete en‐bloc, and curative resection rates were 97% (35/36), 97% (35/36), and 81% (29/36), respectively. The rate of severe bleeding during the procedure was 11% (4/36); however, it could be controlled endoscopically in all patients. The rate of intraoperative perforation and delayed bleeding was 0% (0/36). Delayed perforations occurred in one patient that required surgery. A long procedure time was correlated with the location of the flexure and poor endoscope operability. No recurrence was observed in any patient. None of the patients died of colorectal carcinoma.Conclusions: Our results showed the feasibility and safety of endoscopic submucosal dissection for large pedunculated colorectal carcinomas.
- 1 June 2021
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 93 (6) , AB82-AB83
ID: 3520136 RISK OF METASTATIC RECURRENCE AFTER ADDITIONAL SURGERY IN RELATION TO THE VERTICAL TUMOR MARGIN OF ENDOSCOPIC RESECTION FOR T1B COLORECTAL CARCINOMA
- 1 June 2021
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 93 (6) , AB82-AB83
ID: 3520136 RISK OF METASTATIC RECURRENCE AFTER ADDITIONAL SURGERY IN RELATION TO THE VERTICAL TUMOR MARGIN OF ENDOSCOPIC RESECTION FOR T1B COLORECTAL CARCINOMA
- Open Access
- 8 May 2021
- Published by Wiley in Cancer Science
- Vol. 112 (7) , 2692-2704
Role of tumor‐associated macrophages at the invasive front in human colorectal cancer progression
Macrophages are an essential component of antitumor activity; however, the role of tumor‐associated macrophages (TAMs) in colorectal cancer (CRC) remains controversial. Here, we elucidated the role of TAMs in CRC progression, especially at the early stage. We assessed the TAM number, phenotype, and distribution in 53 patients with colorectal neoplasia, including intramucosal neoplasia, submucosal invasive colorectal cancer (SM‐CRC), and advanced cancer, using double immunofluorescence for CD68 and CD163. Next, we focused on the invasive front in SM‐CRC and association between TAMs and clinicopathological features including lymph node metastasis, which were evaluated in 87 SM‐CRC clinical specimens. The number of M2 macrophages increased with tumor progression and dynamic changes were observed with respect to the number and phenotype of TAMs at the invasive front, especially at the stage of submucosal invasion. A high M2 macrophage count at the invasive front was correlated with lymphovascular invasion, low histological differentiation, and lymph node metastasis; a low M1 macrophage count at the invasive front was correlated with lymph node metastasis. Furthermore, receiver operating characteristic curve analysis revealed that the M2/M1 ratio was a better predictor of the risk of lymph node metastasis than the pan‐, M1, or M2 macrophage counts at the invasive front. These results suggested that TAMs at the invasive front might play a role in CRC progression, especially at the early stages. Therefore, evaluating the TAM phenotype, number, and distribution may be a potential predictor of metastasis, including lymph node metastasis, and TAMs may be a potential CRC therapeutic target.
- 8 May 2021
- Published by Wiley in Cancer Science
- Vol. 112 (7) , 2692-2704
Open AccessRole of tumor‐associated macrophages at the invasive front in human colorectal cancer progression
Macrophages are an essential component of antitumor activity; however, the role of tumor‐associated macrophages (TAMs) in colorectal cancer (CRC) remains controversial. Here, we elucidated the role of TAMs in CRC progression, especially at the early stage. We assessed the TAM number, phenotype, and distribution in 53 patients with colorectal neoplasia, including intramucosal neoplasia, submucosal invasive colorectal cancer (SM‐CRC), and advanced cancer, using double immunofluorescence for CD68 and CD163. Next, we focused on the invasive front in SM‐CRC and association between TAMs and clinicopathological features including lymph node metastasis, which were evaluated in 87 SM‐CRC clinical specimens. The number of M2 macrophages increased with tumor progression and dynamic changes were observed with respect to the number and phenotype of TAMs at the invasive front, especially at the stage of submucosal invasion. A high M2 macrophage count at the invasive front was correlated with lymphovascular invasion, low histological differentiation, and lymph node metastasis; a low M1 macrophage count at the invasive front was correlated with lymph node metastasis. Furthermore, receiver operating characteristic curve analysis revealed that the M2/M1 ratio was a better predictor of the risk of lymph node metastasis than the pan‐, M1, or M2 macrophage counts at the invasive front. These results suggested that TAMs at the invasive front might play a role in CRC progression, especially at the early stages. Therefore, evaluating the TAM phenotype, number, and distribution may be a potential predictor of metastasis, including lymph node metastasis, and TAMs may be a potential CRC therapeutic target.
- 1 June 2019
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 89 (6) , AB388
Su1707 THE UTILITY OF A NOVEL COLONOSCOPE WITH RETROFLEXION FOR COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION
- 1 June 2019
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 89 (6) , AB388
Su1707 THE UTILITY OF A NOVEL COLONOSCOPE WITH RETROFLEXION FOR COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION